Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc. (CPMV) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CPMV · as of Jun 30, 2024
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q1
$1
Total Inst. Value
▲ $1 vs Q1
7.24M
Shares Outstanding
freeFloat 11.32%
1
13F Shares Held
▲ 1 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CPMV largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
WEST OAK CAPITAL, LLC biological products, (no diagnostic substances) | 1 | 0.00% | 0.00% | $1,000 | Jul 24, 2024 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CPMV insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
KING STEVEN W President and CEO | Feb 18, 2022 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
FELCYN GLORIA director | Feb 18, 2022 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
GARNICK ROBERT L director | Feb 18, 2022 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
BAFFI ROBERT director | Feb 18, 2022 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
Steinmetz Nicole Franziska
| Feb 18, 2022 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
GARNICK ROBERT L director | May 7, 2021 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
FELCYN GLORIA director | May 7, 2021 | J-Other | 0 | — | — | 0 | Form 4 ↗ |
Steinmetz Nicole Franziska
| Apr 29, 2021 | Award | 5,357 | — | — | 5.4K | Form 4 ↗ |
Steinmetz Nicole Franziska Acting CSO | Jan 29, 2021 | C-Conversion | 1,641,252 | — | — | 1.64M | Form 4 ↗ |
Steinmetz Nicole Franziska Acting CSO | Jan 29, 2021 | C-Conversion | 570,870 | — | — | 570.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Mosaic ImmunoEngineering Inc. (CPMV) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 88.68%, while retail and public investors account for the remaining 11.32%.
The largest institutional shareholder of Mosaic ImmunoEngineering Inc. is WEST OAK CAPITAL, LLC, holding approximately 1 shares — equal to — of outstanding shares — as of June 30, 2024.
A total of 1 institutional investors currently hold CPMV stock, with a combined institutional value of approximately $1 as of the most recent 13F filing period.
Frequently asked questions
CPMV ownershipMosaic ImmunoEngineering Inc. (CPMV) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is WEST OAK CAPITAL, LLC with a — stake. Company insiders hold 88.68%. Data sourced from SEC Form 13F as of June 30, 2024.